Novartis May Sell Vaccines Unit Separately From Animal Health Business -Bloomberg
February 04 2014 - 1:45PM
Dow Jones News
Novartis AG (NVS, NOVN.VX) may sell its vaccines unit
separately, instead of a plan to sell the division in combination
with its animal health unit, Bloomberg News reported Tuesday,
citing people with knowledge of the matter.
The vaccines business could be valued at around $1 billion, one
person told Bloomberg.
The Bloomberg story said Novartis is still in talks with Merck
about a potential asset swap, although an agreement on valuation
has been "difficult."
Full story at
http://www.bloomberg.com/news/2014-02-04/novartis-said-to-draw-interest-for-vaccines-business.html
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Apr 2024 to May 2024
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From May 2023 to May 2024